FTC Staff Comment: FDA Should Reevaluate Its Current Regulatory Framework for Homeopathic Products

Comment Precedes September 21 FTC Workshop on Homeopathic Drug Advertising
The staff of the Federal Trade Commission has recommended that the U

See the full post at FTC.gov